IMTX
Price
$5.59
Change
+$0.05 (+0.90%)
Updated
Jul 2 closing price
Capitalization
673.39M
40 days until earnings call
OCUL
Price
$9.46
Change
+$0.36 (+3.96%)
Updated
Jul 2 closing price
Capitalization
1.51B
39 days until earnings call
Interact to see
Advertisement

IMTX vs OCUL

Header iconIMTX vs OCUL Comparison
Open Charts IMTX vs OCULBanner chart's image
Immatics
Price$5.59
Change+$0.05 (+0.90%)
Volume$319.27K
Capitalization673.39M
Ocular Therapeutix
Price$9.46
Change+$0.36 (+3.96%)
Volume$3.09M
Capitalization1.51B
IMTX vs OCUL Comparison Chart in %
Loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. OCUL commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Buy and OCUL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (IMTX: $5.59 vs. OCUL: $9.46)
Brand notoriety: IMTX and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 45% vs. OCUL: 138%
Market capitalization -- IMTX: $673.39M vs. OCUL: $1.51B
IMTX [@Biotechnology] is valued at $673.39M. OCUL’s [@Biotechnology] market capitalization is $1.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, OCUL is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 4 TA indicator(s) are bullish while OCUL’s TA Score has 5 bullish TA indicator(s).

  • IMTX’s TA Score: 4 bullish, 4 bearish.
  • OCUL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, OCUL is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а +2.38% price change this week, while OCUL (@Biotechnology) price change was +2.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

IMTX is expected to report earnings on Aug 12, 2025.

OCUL is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.51B) has a higher market cap than IMTX($673M). OCUL YTD gains are higher at: 10.773 vs. IMTX (-21.378). IMTX has higher annual earnings (EBITDA): -4.49M vs. OCUL (-176.35M). IMTX has more cash in the bank: 544M vs. OCUL (350M). IMTX has less debt than OCUL: IMTX (18.4M) vs OCUL (76.2M). IMTX has higher revenues than OCUL: IMTX (144M) vs OCUL (59.6M).
IMTXOCULIMTX / OCUL
Capitalization673M1.51B45%
EBITDA-4.49M-176.35M3%
Gain YTD-21.37810.773-198%
P/E Ratio27.61N/A-
Revenue144M59.6M242%
Total Cash544M350M155%
Total Debt18.4M76.2M24%
FUNDAMENTALS RATINGS
IMTX vs OCUL: Fundamental Ratings
IMTX
OCUL
OUTLOOK RATING
1..100
7613
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
9097
PRICE GROWTH RATING
1..100
5942
P/E GROWTH RATING
1..100
69100
SEASONALITY SCORE
1..100
14n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OCUL's Valuation (54) in the Pharmaceuticals Other industry is in the same range as IMTX (62) in the null industry. This means that OCUL’s stock grew similarly to IMTX’s over the last 12 months.

OCUL's Profit vs Risk Rating (87) in the Pharmaceuticals Other industry is in the same range as IMTX (100) in the null industry. This means that OCUL’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (90) in the null industry is in the same range as OCUL (97) in the Pharmaceuticals Other industry. This means that IMTX’s stock grew similarly to OCUL’s over the last 12 months.

OCUL's Price Growth Rating (42) in the Pharmaceuticals Other industry is in the same range as IMTX (59) in the null industry. This means that OCUL’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's P/E Growth Rating (69) in the null industry is in the same range as OCUL (100) in the Pharmaceuticals Other industry. This means that IMTX’s stock grew similarly to OCUL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXOCUL
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIFEX12.36N/A
N/A
MFS Diversified Income R2
PJGRX48.53N/A
N/A
PGIM Jennison Growth R
PIPTX17.38N/A
N/A
Virtus KAR Global Quality Dividend I
MLVKX32.14N/A
N/A
BlackRock Advantage Large Cap Val K
MSTVX10.70N/A
N/A
Morningstar Alternatives

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with OCUL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+0.90%
OCUL - IMTX
48%
Loosely correlated
+3.96%
KYMR - IMTX
47%
Loosely correlated
+0.20%
CRNX - IMTX
47%
Loosely correlated
+2.40%
CGON - IMTX
47%
Loosely correlated
+1.25%
RGNX - IMTX
46%
Loosely correlated
+4.74%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+3.96%
EYPT - OCUL
58%
Loosely correlated
+1.15%
DNLI - OCUL
55%
Loosely correlated
+6.81%
NRIX - OCUL
52%
Loosely correlated
+6.23%
CRNX - OCUL
52%
Loosely correlated
+2.40%
RNA - OCUL
51%
Loosely correlated
+3.20%
More